XML 140 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Income Tax (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax [Abstract]  
Schedule of Income Tax Expense (Benefit) Computed using the Federal Statutory Income Tax Rate to the Company’s Effective Income Tax Rate

The reconciliation of the statutory federal income tax rate to the Company’s effective tax rate for the year ended December 31, 2024 was as follows:

 

Year Ended
December 31,
2024

U.S. federal statutory rate

 

21.0

%

Increase (decrease) due to:

   

 

State income taxes, net of federal income tax benefit

 

5.6

%

Change in fair value of Earnout, True-up and Subject Vesting liabilities

 

(2.2

)%

Costs related to Business Combination

 

3.7

%

Other permanent adjustments

 

(0.7

)%

Effective tax rate

 

27.4

%

A reconciliation of the expected income tax expense (benefit) computed using the federal statutory income tax rate to the Company’s effective income tax rate is as follows for the year ended December 31, 2024:

 

Year Ended
December 31,
2024

Income tax expense computed at federal statutory tax rate

 

$

62,359,838

 

Increase (decrease) due to:

 

 

 

 

State income taxes, net of federal income tax benefit

 

 

16,454,870

 

Change in fair value of Earnout, True-up and Subject Vesting liabilities

 

 

(6,622,560

)

Costs related to Business Combination

 

 

11,021,988

 

Other permanent adjustments

 

 

(1,958,089

)

Total income tax expense

 

$

81,256,047

 

Schedule of Components of Income Tax Expense (Benefit)

The components of income tax expense are as follows:

 

Year Ended
December 31,
2024

Federal

 

 

 

Current tax expense

 

$

Deferred tax expense

 

 

60,427,097

Total federal

 

 

60,427,097

   

 

 

State and local

 

 

 

Current tax expense

 

 

Deferred tax expense

 

 

20,828,950

Total state and local

 

 

20,828,950

Total income tax expense

 

$

81,256,047

Schedule of Rise to Deferred Tax Assets and Liabilities The temporary differences that give rise to deferred tax assets and liabilities are as follows:
 

Year Ended
December 31,
2024

Deferred tax assets

 

 

 

Net operating losses

 

$

2,894,110

Share-based compensation and other accrued expenses

 

 

621,958

Start-up costs

 

 

778,644

Capitalized R&D expense

 

 

1,287,402

Lease liabilities

 

 

40,611

Total deferred tax asset

 

 

5,622,725

   

 

 

Deferred tax liabilities

 

 

 

Outside basis in joint venture

 

 

86,839,767

Right-of-use asset

 

 

38,709

Other

 

 

296

Total deferred tax liability

 

 

86,878,772

Net deferred tax liabilities

 

$

81,256,047